Cargando…

Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial

BACKGROUND: Pisa syndrome (PS) is a frequent postural complication of Parkinson's disease (PD). PS poorly responds to anti-parkinsonian drugs and the improvement achieved with neurorehabilitation tends to fade in 6 months or less. Transcranial direct current stimulation (t-DCS) is a non-invasiv...

Descripción completa

Detalles Bibliográficos
Autores principales: De Icco, Roberto, Putortì, Alessia, Allena, Marta, Avenali, Micol, Dagna, Carlotta, Martinelli, Daniele, Cristina, Silvano, Grillo, Valentina, Fresia, Mauro, Bitetto, Vito, Cosentino, Giuseppe, Valentino, Francesca, Alfonsi, Enrico, Sandrini, Giorgio, Pisani, Antonio, Tassorelli, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046718/
https://www.ncbi.nlm.nih.gov/pubmed/35493824
http://dx.doi.org/10.3389/fneur.2022.849820
_version_ 1784695571231014912
author De Icco, Roberto
Putortì, Alessia
Allena, Marta
Avenali, Micol
Dagna, Carlotta
Martinelli, Daniele
Cristina, Silvano
Grillo, Valentina
Fresia, Mauro
Bitetto, Vito
Cosentino, Giuseppe
Valentino, Francesca
Alfonsi, Enrico
Sandrini, Giorgio
Pisani, Antonio
Tassorelli, Cristina
author_facet De Icco, Roberto
Putortì, Alessia
Allena, Marta
Avenali, Micol
Dagna, Carlotta
Martinelli, Daniele
Cristina, Silvano
Grillo, Valentina
Fresia, Mauro
Bitetto, Vito
Cosentino, Giuseppe
Valentino, Francesca
Alfonsi, Enrico
Sandrini, Giorgio
Pisani, Antonio
Tassorelli, Cristina
author_sort De Icco, Roberto
collection PubMed
description BACKGROUND: Pisa syndrome (PS) is a frequent postural complication of Parkinson's disease (PD). PS poorly responds to anti-parkinsonian drugs and the improvement achieved with neurorehabilitation tends to fade in 6 months or less. Transcranial direct current stimulation (t-DCS) is a non-invasive neuromodulation technique that showed promising results in improving specific symptoms in different movement disorders. OBJECTIVES: This study aimed to evaluate the role of bi-hemispheric t-DCS as an add-on to a standardized hospital rehabilitation program in the management of PS in PD. METHODS: This study included 28 patients with PD and PS (21 men, aged 72.9 ± 5.1 years) who underwent a 4-week intensive neurorehabilitation treatment and were randomized to receive: i) t-DCS (t-DCS group, n = 13) for 5 daily sessions (20 min−2 mA) with bi-hemispheric stimulation over the primary motor cortex (M1), or ii) sham stimulation (sham group, n = 15) with the same duration and cadence. At baseline (T0), end of rehabilitation (T1), and 6 months later (T2) patients were evaluated with both trunk kinematic analysis and clinical scales, including UPDRS-III, Functional Independence Measure (FIM), and Numerical Rating Scale for lumbar pain. RESULTS: When compared to the sham group, the t-DCS group achieved a more pronounced improvement in several variables: overall posture (p = 0.014), lateral trunk inclination (p = 0.013) during upright standing position, total range of motion of the trunk (p = 0.012), FIM score (p = 0.048), and lumbar pain intensity (p = 0.017). CONCLUSIONS: Our data support the use of neuromodulation with t-DCS as an add-on to neurorehabilitation for the treatment of patients affected by PS in PD.
format Online
Article
Text
id pubmed-9046718
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90467182022-04-29 Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial De Icco, Roberto Putortì, Alessia Allena, Marta Avenali, Micol Dagna, Carlotta Martinelli, Daniele Cristina, Silvano Grillo, Valentina Fresia, Mauro Bitetto, Vito Cosentino, Giuseppe Valentino, Francesca Alfonsi, Enrico Sandrini, Giorgio Pisani, Antonio Tassorelli, Cristina Front Neurol Neurology BACKGROUND: Pisa syndrome (PS) is a frequent postural complication of Parkinson's disease (PD). PS poorly responds to anti-parkinsonian drugs and the improvement achieved with neurorehabilitation tends to fade in 6 months or less. Transcranial direct current stimulation (t-DCS) is a non-invasive neuromodulation technique that showed promising results in improving specific symptoms in different movement disorders. OBJECTIVES: This study aimed to evaluate the role of bi-hemispheric t-DCS as an add-on to a standardized hospital rehabilitation program in the management of PS in PD. METHODS: This study included 28 patients with PD and PS (21 men, aged 72.9 ± 5.1 years) who underwent a 4-week intensive neurorehabilitation treatment and were randomized to receive: i) t-DCS (t-DCS group, n = 13) for 5 daily sessions (20 min−2 mA) with bi-hemispheric stimulation over the primary motor cortex (M1), or ii) sham stimulation (sham group, n = 15) with the same duration and cadence. At baseline (T0), end of rehabilitation (T1), and 6 months later (T2) patients were evaluated with both trunk kinematic analysis and clinical scales, including UPDRS-III, Functional Independence Measure (FIM), and Numerical Rating Scale for lumbar pain. RESULTS: When compared to the sham group, the t-DCS group achieved a more pronounced improvement in several variables: overall posture (p = 0.014), lateral trunk inclination (p = 0.013) during upright standing position, total range of motion of the trunk (p = 0.012), FIM score (p = 0.048), and lumbar pain intensity (p = 0.017). CONCLUSIONS: Our data support the use of neuromodulation with t-DCS as an add-on to neurorehabilitation for the treatment of patients affected by PS in PD. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9046718/ /pubmed/35493824 http://dx.doi.org/10.3389/fneur.2022.849820 Text en Copyright © 2022 De Icco, Putortì, Allena, Avenali, Dagna, Martinelli, Cristina, Grillo, Fresia, Bitetto, Cosentino, Valentino, Alfonsi, Sandrini, Pisani and Tassorelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
De Icco, Roberto
Putortì, Alessia
Allena, Marta
Avenali, Micol
Dagna, Carlotta
Martinelli, Daniele
Cristina, Silvano
Grillo, Valentina
Fresia, Mauro
Bitetto, Vito
Cosentino, Giuseppe
Valentino, Francesca
Alfonsi, Enrico
Sandrini, Giorgio
Pisani, Antonio
Tassorelli, Cristina
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial
title Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial
title_full Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial
title_fullStr Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial
title_full_unstemmed Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial
title_short Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial
title_sort non-invasive neuromodulation in the rehabilitation of pisa syndrome in parkinson's disease: a randomized controlled trial
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046718/
https://www.ncbi.nlm.nih.gov/pubmed/35493824
http://dx.doi.org/10.3389/fneur.2022.849820
work_keys_str_mv AT deiccoroberto noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT putortialessia noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT allenamarta noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT avenalimicol noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT dagnacarlotta noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT martinellidaniele noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT cristinasilvano noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT grillovalentina noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT fresiamauro noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT bitettovito noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT cosentinogiuseppe noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT valentinofrancesca noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT alfonsienrico noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT sandrinigiorgio noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT pisaniantonio noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial
AT tassorellicristina noninvasiveneuromodulationintherehabilitationofpisasyndromeinparkinsonsdiseasearandomizedcontrolledtrial